"A series of new histone deacetylase inhibitors were designed and synthesized based on hybridization between SAHA or oxamflatin and 5-phenyl-1,4-benzodiazepines. The compounds were tested for their enzyme inhibitory activity on HeLa nuclear extracts, and on human recombinant HDAC1 and HDAC6. Antiproliferative activity was tested on different cancer cells types, while proapoptotic activity was primarily tested on NB4 cells. The compounds showed IC50 values similar to those of SAHA. Compound (S)-8 displayed interesting activity against hematological and solid malignancies.
Histone deacetylase (HDAC) proteins have become an important target for the treatment of several dis...
Histone deacetylase 6 (HDAC6) selective inhibitors represent an emerging class of pharmaceuticals du...
The development of new anticancer drugs is necessary in order deal with the disease and with the dra...
"A series of new histone deacetylase inhibitors were designed and synthesized based on hybridization...
Histone deacetylase (HDAC) inhibitors are used as anticancer agents. Isoform selective HDAC inhibito...
Herein, we report the development of a new series of histone deacetylase inhibitors (HDACi) containi...
Synthesis, computational study and biological evaluation of peptidomimetic analogues of FR235222 (3)...
Given our interest in finding potential antitumor agents and in view of the multifactorial mechanist...
In this work, we report the multicomponent synthesis of a focused histone deacetylase (HDAC) inhibit...
Synthesis, computational study and biological evaluation of peptidomimetic analogues of FR235222 (3)...
Histone deacetylases (HDACs) are attractive therapeutic targets for the treatment of cancer and othe...
A series of isoxazole-based histone deacetylase (HDAC) inhibitors structurally related to SAHA were ...
Histone deacetylase (HDAC) proteins have become an important target for the treatment of several dis...
Histone deacetylase 6 (HDAC6) selective inhibitors represent an emerging class of pharmaceuticals du...
The development of new anticancer drugs is necessary in order deal with the disease and with the dra...
"A series of new histone deacetylase inhibitors were designed and synthesized based on hybridization...
Histone deacetylase (HDAC) inhibitors are used as anticancer agents. Isoform selective HDAC inhibito...
Herein, we report the development of a new series of histone deacetylase inhibitors (HDACi) containi...
Synthesis, computational study and biological evaluation of peptidomimetic analogues of FR235222 (3)...
Given our interest in finding potential antitumor agents and in view of the multifactorial mechanist...
In this work, we report the multicomponent synthesis of a focused histone deacetylase (HDAC) inhibit...
Synthesis, computational study and biological evaluation of peptidomimetic analogues of FR235222 (3)...
Histone deacetylases (HDACs) are attractive therapeutic targets for the treatment of cancer and othe...
A series of isoxazole-based histone deacetylase (HDAC) inhibitors structurally related to SAHA were ...
Histone deacetylase (HDAC) proteins have become an important target for the treatment of several dis...
Histone deacetylase 6 (HDAC6) selective inhibitors represent an emerging class of pharmaceuticals du...
The development of new anticancer drugs is necessary in order deal with the disease and with the dra...